Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer: safety and efficacy outcomes from an open-label, dose-escalation, single-center, phase I/II clinical trial
{{custom_author.name}}, {{article.zuoZheEn}}
Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer: safety and efficacy outcomes from an open-label, dose-escalation, single-center, phase I/II clinical trial
[{{custom_ref.label}}] |
{{custom_citation.content}}
CrossRef
Pubmed
arXiv
Google scholar
|
/
〈 | 〉 |